Combined Antagonistic Muscle Magnetic Stimulation and Selective Periferal Neurotomy to Improve Results on Spasticity

ConditionSTROKE

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age25+

SponsorJuan Carlos M. Andreani MD

About this trial

The objective of the present trial is to demonstrate Magnetic stimulation as an useful complementary treatment in order to improve patients' evolution without the need of extensive surgical lesion.

Eligibility criteria

Qualifiers

Severe and refractory right Hemiparesia or Hemiplegia, affecting hand function.

Failure of kinesic treatment

2 points or more Improvement on Modified Ashworth Scale after anestethic blockade

Disqualifiers

Severe cardiovascular disease

Severe pulmonary disease

Neoplasia advanced disease

Joint anchylosis

Trial design

Treatments tested in this trial

- Postoperative Antagonistic Peripheral Magnetic Stimulation
Selective Peripheral Magnetic Stimulation
Kinesics

Treatment groups

15 Participants

are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Juan Carlos M. Andreani MD

Lead sponsor

Sociedad Argenttina de Neuromodulación

Sponsor institution

Source ClinicalTrials.gov